Sigilon Therapeutics, Inc.

Sigilon Therapeutics, Inc.

SGTX
Sigilon Therapeutics, Inc.US flagNASDAQ Global Select
22.47
USD
-0.59
- -
56.22MMarket Cap

Sigilon Therapeutics, Inc. (SGTX) Stock Splits

Learn about Sigilon Therapeutics, Inc.'s most recent 1-for-13 basis stock split on May 23, 2023. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Sigilon Therapeutics, Inc.'s most recent stock split

Split Date: 2023-05-23
Split Ratio: 1:13
Price Before Split: $0.56
Price After Split: $0.04

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 13.00 times fewer shares (a 1:13 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Sigilon Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2023-05-231:13Yes$0.56$0.04

About Sigilon Therapeutics, Inc.

Company overview and industry information

Sigilon Therapeutics, Inc. (SGTX) operates in the Biotechnology industry. The recent 1-for-13 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Sigilon Therapeutics, Inc. Summary

Last updated: 6/3/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.